Genprex, Inc.
(NASDAQ : GNPX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.01%150.100.7%$1012.27m
ABBVAbbVie, Inc. -1.38%94.032.3%$1007.39m
MRKMerck & Co., Inc. 0.82%82.640.7%$980.10m
PFEPfizer Inc. -1.16%36.500.9%$930.84m
BMYBristol-Myers Squibb Co. 0.47%66.391.0%$846.94m
LLYEli Lilly & Co. -0.45%141.161.1%$504.56m
NVSNovartis AG -0.12%97.650.2%$213.07m
GSKGlaxoSmithKline Plc -0.09%43.740.2%$162.90m
AZNAstraZeneca Plc -3.00%47.851.2%$136.58m
RETAReata Pharmaceuticals, Inc. -1.90%225.653.5%$92.90m
NVONovo Nordisk A/S 1.12%63.440.1%$87.00m
BHCBausch Health Cos., Inc. 1.15%27.750.0%$84.59m
SNYSanofi -0.14%49.930.2%$72.94m
GNPXGenprex, Inc. 56.20%4.280.0%$63.77m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.64%45.340.0%$60.88m

Company Profile

Genprex, Inc. is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors. The company was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.